BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:46 PM
Apr 24, 2008
 |  BC Extra  |  Company News

Shire acquires enzyme replacement therapy

Shire (LSE:SHP; NASDAQ:SHPGY) will acquire Metazym from Zymenex (Hillerod, Denmark) for $135 million in cash. The recombinant human...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >